HOLOGIC INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 32 rows in 2023. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-12-15: Reporting owner Dunne Peter Paul; Form 3; Security Non-qualified Stock Option (Right to Buy); Transaction Holding.
- 2023-12-15: Reporting owner Dunne Peter Paul; Form 3; Security Non-qualified Stock Option (Right to Buy); Transaction Holding.
- 2023-12-15: Reporting owner Dunne Peter Paul; Form 3; Security Non-qualified Stock Option (Right to Buy); Transaction Holding.
- 2023-12-15: Reporting owner Dunne Peter Paul; Form 3; Security Non-qualified Stock Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-12-15 holding as of filing | Dunne Peter Paul Officer (SVP, Human Resources) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $37.64 exercise price | 2023-12-15 | ||
| 2023-12-15 holding as of filing | Dunne Peter Paul Officer (SVP, Human Resources) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $40.85 exercise price | 2023-12-15 | ||
| 2023-12-15 holding as of filing | Dunne Peter Paul Officer (SVP, Human Resources) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $40.97 exercise price | 2023-12-15 | ||
| 2023-12-15 holding as of filing | Dunne Peter Paul Officer (SVP, Human Resources) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $45.61 exercise price | 2023-12-15 | ||
| 2023-12-15 holding as of filing | Dunne Peter Paul Officer (SVP, Human Resources) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $68.35 exercise price | 2023-12-15 | ||
| 2023-12-15 holding as of filing | Dunne Peter Paul Officer (SVP, Human Resources) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $71.13 exercise price | 2023-12-15 | ||
| 2023-12-15 holding as of filing | Dunne Peter Paul Officer (SVP, Human Resources) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $74.35 exercise price | 2023-12-15 | ||
| 2023-12-15 holding as of filing | Dunne Peter Paul Officer (SVP, Human Resources) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $71.94 exercise price | 2023-12-15 | ||
| 2023-12-13 | Dunne Peter Paul Officer (SVP, Human Resources) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,554 3,554 owned after | $71.03 exercise price | 2023-12-15 | |
| 2023-11-29 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −47,711 47,711 owned after | $26.21 exercise price | 2023-12-01 | |
| 2023-11-14 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +117,829 117,829 owned after | $71.94 exercise price | 2023-11-16 | |
| 2023-11-14 | Oberton Karleen Marie Officer (Chief Financial Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,070 25,070 owned after | $71.94 exercise price | 2023-11-16 | |
| 2023-11-14 | Verstreken Jan Officer (Group President, International) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,056 20,056 owned after | $71.94 exercise price | 2023-11-16 | |
| 2023-11-14 | Schneiders Jennifer M Officer (President, Diag. Solutions) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,028 10,028 owned after | $71.94 exercise price | 2023-11-16 | |
| 2023-11-14 | Mitchell Essex D Officer (Div. President, GYN Surgical) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,070 25,070 owned after | $71.94 exercise price | 2023-11-16 | |
| 2023-11-14 | Hellmann Elisabeth A Officer (SVP, Human Resources) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,011 4,011 owned after | $71.94 exercise price | 2023-11-16 | |
| 2023-11-14 | Griffin John M. Officer (General Counsel) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,056 20,056 owned after | $71.94 exercise price | 2023-11-16 | |
| 2023-11-14 | COHN BENJAMIN JORDAN Officer (Principal Accounting Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,509 3,509 owned after | $71.94 exercise price | 2023-11-16 | |
| 2023-11-14 | Anderson Erik S Officer (Div. Pres., Breast & Skeletal) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,030 11,030 owned after | $71.94 exercise price | 2023-11-16 | |
| 2023-09-20 | Mohtashami Nanaz Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,141 2,141 owned after | $71.45 exercise price | 2023-09-22 | |
| 2023-06-23 holding as of filing | Schneiders Jennifer M Officer (President, Diag. Solutions) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $71.13 exercise price | 2023-06-23 | ||
| 2023-06-23 holding as of filing | Schneiders Jennifer M Officer (President, Diag. Solutions) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $74.35 exercise price | 2023-06-23 | ||
| 2023-03-09 | Wendell Amy McBride Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,210 4,210 owned after | $78.49 exercise price | 2023-03-13 | |
| 2023-03-09 | Stewart Stacey D. Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,210 4,210 owned after | $78.49 exercise price | 2023-03-13 | |
| 2023-03-09 | Stamoulis Christiana Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,210 4,210 owned after | $78.49 exercise price | 2023-03-13 | |
| 2023-03-09 | Nawana Namal Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,210 4,210 owned after | $78.49 exercise price | 2023-03-13 | |
| 2023-03-09 | HANTSON LUDWIG Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,210 4,210 owned after | $78.49 exercise price | 2023-03-13 | |
| 2023-03-09 | GARRETT SCOTT T Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,210 4,210 owned after | $78.49 exercise price | 2023-03-13 | |
| 2023-03-09 | Dockendorff Charles J Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,210 4,210 owned after | $78.49 exercise price | 2023-03-13 | |
| 2023-03-09 | CRAWFORD SALLY Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,210 4,210 owned after | $78.49 exercise price | 2023-03-13 | |
| 2023-02-07 | COHN BENJAMIN JORDAN Officer (Principal Accounting Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,128 0 owned after | $40.97 exercise price | 2023-02-09 | |
| 2023-01-02 | Stewart Stacey D. Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +768 768 owned after | $74.81 exercise price | 2023-01-04 |